Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70526 - 70550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	FANCA	2175	upregulated	Silicon Dioxide analog results in increased expression of FANCA mRNA	16q24.3	A24195
Silicon dioxide	Approved	FANCD2	2177	upregulated	Silicon Dioxide analog results in increased expression of FANCD2 mRNA	3p25.3	A24195
Silicon dioxide	Approved	FANK1	92565	downregulated	Silicon Dioxide analog results in decreased expression of FANK1 mRNA	10q26.2	A24195
Silicon dioxide	Approved	FAP	2191	upregulated	Silicon Dioxide analog results in increased expression of FAP mRNA	2q24.2	A24194
Silicon dioxide	Approved	FAR2	55711	downregulated	Silicon Dioxide analog results in decreased expression of FAR2 mRNA	12p11.22	A24195
Silicon dioxide	Approved	FARP2	9855	downregulated	Silicon Dioxide analog results in decreased expression of FARP2 mRNA	2q37.3	A24195
Silicon dioxide	Approved	FAS	355	upregulated	Silicon Dioxide results in increased expression of FAS mRNA	10q23.31	A24196
Silicon dioxide	Approved	FASTKD5	60493	upregulated	Silicon Dioxide results in increased expression of FASTKD5 mRNA	20p13	A24196
Silicon dioxide	Approved	FAT3	120114	downregulated	Silicon Dioxide analog results in decreased expression of FAT3 mRNA	11q14.3	A24195
Silicon dioxide	Approved	FAT4	79633	upregulated	Silicon Dioxide results in increased expression of FAT4 mRNA	4q28.1	A24196
Silicon dioxide	Approved	FAXDC2	10826	downregulated	Silicon Dioxide analog results in decreased expression of FAXDC2 mRNA	5q33.2	A24195
Silicon dioxide	Approved	FAXDC2	10826	downregulated	Silicon Dioxide results in decreased expression of FAXDC2 mRNA	5q33.2	A24196
Silicon dioxide	Approved	FBLN1	2192	downregulated	Silicon Dioxide analog results in decreased expression of FBLN1 mRNA	22q13.31	A24195
Silicon dioxide	Approved	FBLN1	2192	upregulated	Silicon Dioxide analog results in increased expression of FBLN1 mRNA	22q13.31	A24194
Silicon dioxide	Approved	FBLN2	2199	downregulated	Silicon Dioxide analog results in decreased expression of FBLN2 mRNA	3p25.1	A24195
Silicon dioxide	Approved	FBLN5	10516	downregulated	Silicon Dioxide analog results in decreased expression of FBLN5 mRNA	14q32.12	A24195
Silicon dioxide	Approved	FBN2	2201	upregulated	Silicon Dioxide analog results in increased expression of FBN2 mRNA	5q23.3	A24194
Silicon dioxide	Approved	FBRS	64319	upregulated	Silicon Dioxide results in increased expression of FBRS mRNA	16p11.2	A24196
Silicon dioxide	Approved	FBRSL1	57666	downregulated	Silicon Dioxide analog results in decreased expression of FBRSL1 mRNA	12q24.33	A24195
Silicon dioxide	Approved	FBXL14	144699	downregulated	Silicon Dioxide analog results in decreased expression of FBXL14 mRNA	12p13.33	A24195
Silicon dioxide	Approved	FBXL14	144699	downregulated	Silicon Dioxide results in decreased expression of FBXL14 mRNA	12p13.33	A24196
Silicon dioxide	Approved	FBXL16	146330	upregulated	Silicon Dioxide analog results in increased expression of FBXL16 mRNA	16p13.3	A24195
Silicon dioxide	Approved	FBXL4	26235	upregulated	Silicon Dioxide analog results in increased expression of FBXL4 mRNA	6q16.1-q16.2	A24194
Silicon dioxide	Approved	FBXL5	26234	upregulated	Silicon Dioxide results in increased expression of FBXL5 mRNA	4p15.32	A24196
Silicon dioxide	Approved	FBXO15	201456	downregulated	Silicon Dioxide analog results in decreased expression of FBXO15 mRNA	18q22.3	A24195

Displaying entries 70526 - 70550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability